---
title: "Metformin"
specialty_key: "endocrinology"
drug_class: "Biguanide"
urgency: "routine"
last_updated: 2025-10-05
categories: [diabetes, oral-medication]
tags: [metformin, diabetes, first-line, oral-medication]
author: "Dr. Fuad Jaafar"
description: "Clinical information and prescribing guidelines for Metformin"
---


# Metformin (Metformin Hydrochloride)

## Overview
Metformin is the first-line oral antidiabetic medication for Type 2 Diabetes Mellitus, belonging to the biguanide class of drugs.

## Mechanism of Action
- **Primary**: Decreases hepatic glucose production
- **Secondary**: Improves insulin sensitivity in peripheral tissues
- **Additional**: Reduces intestinal glucose absorption
- **No effect**: Does not stimulate insulin secretion

## Indications

### Primary
- **Type 2 Diabetes Mellitus**: First-line therapy
- **Prediabetes**: Prevention of progression (off-label)

### Secondary
- **PCOS**: Insulin resistance management (off-label)
- **Weight management**: In diabetic patients

## Dosage and Administration

### Initial Dosing
- **Starting dose**: 500mg twice daily with meals
- **Alternative**: 850mg once daily with dinner
- **Titration**: Increase by 500mg weekly as tolerated

### Maintenance Dosing
- **Usual dose**: 1000mg twice daily
- **Maximum dose**: 2550mg daily (divided doses)
- **Extended-release**: Once daily with evening meal

### Special Populations

**Elderly (≥65 years):**
- Start with lower doses
- Monitor renal function closely
- Consider dose reduction

**Renal Impairment:**
- **eGFR 45-59**: Monitor closely, may continue
- **eGFR 30-44**: Reduce dose by 50%
- **eGFR <30**: Contraindicated

## Contraindications

### Absolute
- Severe renal impairment (eGFR <30 mL/min/1.73m²)
- Acute or chronic metabolic acidosis
- Diabetic ketoacidosis
- Hypersensitivity to metformin

### Relative
- Heart failure requiring pharmacologic treatment
- Liver disease
- Excessive alcohol use
- Age >80 years (unless normal renal function)

## Side Effects

### Common (>10%)
- **Gastrointestinal**: Nausea, vomiting, diarrhea, abdominal pain
- **Taste**: Metallic taste
- **Appetite**: Decreased appetite

### Serious (<1%)
- **Lactic acidosis**: Rare but potentially fatal
- **Vitamin B12 deficiency**: With long-term use

### Management of Side Effects
- **GI symptoms**: Take with food, start low dose, use XR formulation
- **B12 deficiency**: Monitor levels annually, supplement if needed

## Drug Interactions

### Major Interactions
- **Contrast agents**: Hold 48 hours before/after procedures
- **Alcohol**: Increased lactic acidosis risk
- **Carbonic anhydrase inhibitors**: Increased acidosis risk

### Monitoring Required
- **Diuretics**: Monitor renal function
- **ACE inhibitors**: Monitor renal function
- **Corticosteroids**: Monitor glucose control

## Monitoring Parameters

### Baseline
- **Renal function**: Creatinine, eGFR
- **Liver function**: ALT, AST
- **Glucose control**: FBS, HbA1c
- **Vitamin B12**: Baseline level

### Follow-up
- **HbA1c**: Every 3 months until target achieved, then every 6 months
- **Renal function**: Every 6-12 months (more frequent if risk factors)
- **Vitamin B12**: Annually
- **Liver function**: If clinically indicated

## Patient Education

### Key Points
- Take with meals to reduce GI side effects
- Do not skip meals while on medication
- Report persistent nausea, vomiting, or abdominal pain
- Inform healthcare providers about metformin use before procedures

### Sick Day Rules
- Continue medication unless vomiting
- Monitor blood glucose more frequently
- Seek medical attention if unable to maintain fluid intake

## Clinical Pearls

### Advantages
- **Weight**: Weight neutral or modest weight loss
- **Cardiovascular**: Potential cardiovascular benefits
- **Hypoglycemia**: Low risk when used alone
- **Cost**: Inexpensive, generic available

### Considerations
- **Combination therapy**: Often combined with other antidiabetics
- **Surgery**: Hold before major surgery/contrast procedures
- **Pregnancy**: Generally safe, consider insulin transition

## Formulations Available

| Type | Strengths | Frequency |
|------|-----------|----------|
| Immediate Release | 500mg, 850mg, 1000mg | 2-3 times daily |
| Extended Release | 500mg, 750mg, 1000mg | Once daily |

## References
- Malaysian CPG for T2DM Management (2020)
- ADA Standards of Medical Care (2025)
- Metformin Prescribing Information (2024)
- NICE Type 2 Diabetes Guidelines (2024)
